Bone metastasis: pathogenesis and therapeutic implications.
about
The effect of relaxin on the musculoskeletal systemCombination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft modelTumour-derived miRNAs and bone metastasisRANK-mediated signaling network and cancer metastasis.Molecular mechanisms of bone metastasis and associated muscle weakness.New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrenceMetastatic tumors to the jaws and mouth.Breast cancer metastasis to the bone: mechanisms of bone lossBreast cancer at bone metastatic sites: recent discoveries and treatment targets.Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway.Therapeutic targets for bone metastases in breast cancer.Bone Targeted Therapies for Bone Metastasis in Breast CancerBone-Targeted Agents for the Management of Breast Cancer Patients with Bone MetastasesSemaphorin 4D Promotes Skeletal Metastasis in Breast CancerEstablishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer.Thoracic Temporal Subtraction Three Dimensional Computed Tomography (3D-CT): Screening for Vertebral Metastases of Primary Lung Cancers.Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIsBasigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions.Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.Finite element analysis and CT-based structural rigidity analysis to assess failure load in bones with simulated lytic defects.TMPRSS2-ERG fusion promotes prostate cancer metastases in bone.Role of cancer stem cells in spine tumors: review of current literature.Bone metastases in hepatocellular carcinoma: an emerging issue.Src signaling pathways in prostate cancer.Pharmacotherapy of bone metastases in breast cancer patients--an update.Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation.Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation.Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.Development and characterization of murine models of medulloblastoma extraneural growth in bone.Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model.Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption.Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL/RANK signalling really important?Outcomes of metastatic spinal cord compression secondary to primary hepatocellular carcinoma with multidisciplinary treatments.Leptocarpin Suppresses Proliferation, Migration, and Invasion of Human Osteosarcoma by Targeting Type-1 Insulin-Like Growth Factor Receptor (IGF-1R).Alteration of osteoblast arrangement via direct attack by cancer cells: New insights into bone metastasis.WNT5A and Its Receptors in the Bone-Cancer Dialogue.α-Tocopheryl Succinate Inhibits Osteolytic Bone Metastasis of Breast Cancer by Suppressing Migration of Cancer Cells and Receptor Activator of Nuclear Factor-κB Ligand Expression of Osteoblasts.
P2860
Q26828539-6D067AE6-0FAF-44D7-A022-E4726856C4CBQ27302940-0F4FEE14-B24F-467B-9013-D449D041A325Q28086895-F6F8B0C1-513E-4BC9-8660-89E92304AA9BQ30371052-A84FAC91-8948-4B32-BBD5-C6DE5A0453D5Q33758508-D8774D9A-0290-475B-B4D8-7399879CA95CQ34382914-4A6A1556-AE5E-4F25-AE7C-C7A0CDF20FABQ34577367-F034D1EF-5D2F-463F-8C59-95ED3C727796Q34613578-DD614EB9-2CBF-4C2C-8A96-51B0A30103A5Q34939979-AA8F2B2D-4B54-4D08-8764-49AD389569A2Q35423697-4E704165-8BF7-4B2F-A2EF-41899933CD32Q35558919-BA988AB4-A2CF-4C12-886B-0813A30362C5Q35750448-19EC1951-B27C-4048-A6B6-A1A58183F7D9Q35750641-DAC9353D-35B6-4638-B31D-4A7088FA6BD6Q35933921-1728F013-778C-4E20-B3FA-58B5475F6162Q36249328-754913E2-9F10-458E-8E00-D1C0F3F8477BQ36251425-611AE9BB-5326-4329-94D8-1AA778BE7E24Q36385639-8FDEC7A4-928C-4EBF-B195-C4CA82DC7EE9Q36750660-B217B16D-F940-4FEF-B6BF-B41E7CFE886DQ36759878-D2369E6B-D211-4D17-9EBB-E7E1E1698B39Q37056973-D15ACA73-AD3F-43EB-9CFA-CCC27FC5D3A2Q37537907-502E8886-6D2E-44B1-A3A9-1BA47A543710Q37706996-B8D56453-2DF2-4BBD-8496-3C6FA31EB923Q37993701-E5787078-7F57-4BE0-B2AA-E050F5B808CDQ38172848-FAC6142E-D548-439D-9A44-6A23A7116A9BQ38187565-3FA8315C-7231-40C1-BB71-5277DE6CEC11Q38199759-4FB8D558-8BB4-47A1-9FAC-4BD66D15205DQ38503809-2667BE59-FEEF-4144-A82F-86FC50005240Q38686032-CE230AA8-2CD9-4499-B4CC-5D49D036EF1FQ38906451-06DC3789-00A1-4086-85EA-8A59768E3F15Q39152052-2588FE9E-52F3-4881-B501-E429DE95E7A5Q39180907-684A089F-3BCD-4944-8A5A-E0F1256F1389Q39447169-5B96589B-9B6B-4F20-A9A3-B5853481B678Q39453306-57D5FC4B-9EF3-4D3D-8737-1E8F4E8AE955Q39516147-EC0578A4-5EFA-4571-B276-167C6151354CQ39561248-466653BB-37D7-44F4-A036-5EF711C60971Q41092069-071B8D19-367A-4D9C-B28F-4F8A86AA40E9Q41617257-044D72C6-0B03-4739-B162-A38A6C56F408Q41923292-269FB323-1848-4BFA-9A86-D001C8BF3396Q51674853-1C62B561-A91B-4B94-BAFC-C9CA285C445BQ55118190-F87FD369-3FB9-4D25-A642-1CB0418BC1FE
P2860
Bone metastasis: pathogenesis and therapeutic implications.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Bone metastasis: pathogenesis and therapeutic implications.
@ast
Bone metastasis: pathogenesis and therapeutic implications.
@en
Bone metastasis: pathogenesis and therapeutic implications.
@nl
type
label
Bone metastasis: pathogenesis and therapeutic implications.
@ast
Bone metastasis: pathogenesis and therapeutic implications.
@en
Bone metastasis: pathogenesis and therapeutic implications.
@nl
prefLabel
Bone metastasis: pathogenesis and therapeutic implications.
@ast
Bone metastasis: pathogenesis and therapeutic implications.
@en
Bone metastasis: pathogenesis and therapeutic implications.
@nl
P2860
P1476
Bone metastasis: pathogenesis and therapeutic implications.
@en
P2093
Philippe Clezardin
P2860
P2888
P304
P356
10.1007/S10585-007-9112-8
P577
2007-11-16T00:00:00Z
P6179
1046684543